Changes

[[File:V-HeFT Screenshot.png|450px|thumb|right]] The '''V-HeFT Trial is ''' was a clinical trial published in the ''[[New England Journal of Medicine]]'' establishing that therapy with isosorbide dinitrate and hydralazine reduced mortality in patients systolic heart failure. It was named '''V-Heft''' because of these '''very hefty''' results.